: sales@oddwayinternational.com : oddway2010 : +91-9873336444 : +91-11-43526658

Natco Pharma launches (Hepcinat Plus Tablet) Hepatitis C drug in India

Natco Pharma launches (Hepcinat Plus Tablet) Hepatitis C drug in India

Natco Phrama launched the drug for the treatment of Hepatitis C Virus. It is a fixed combination of Sofosbuvir-Daclatasvir tablets under the brand name of Hepcinat Plus in India.

The product is a generic fixed dose combination of Sofosbuvir 400 mg and Daclatasvir 60mg tablets used for the treatment of patients with chronic Hepatitis C virus infection, the company said in a filing to the BSE.

Natco Phrama has launched Hepnicat Plus Tablet at the price of Rs. 17,500; it contains a bottle of 28 tablets.

Hepcinat Plus (Sofosbuvir & Daclatasvir) Details:

Brand Name: Hepcinat Plus
Composition: Sofosbuvir 400mg & Daclatasvir 60mg
Manufactured by: Natco Pharma Ltd.
Packing: Pack of 28 Tablets
Country of Origin: India

Request for Quote

Our App

Customer Service

Payment & Shipping

Connect with us

Contact Us

icon
Address : 4216/20, Ground Floor, 1 Ansari Road, Daryaganj,
New Delhi - 110002 (India)
icon
sales@oddwayinternational.com
QQ : 1523458453@qq.com
icon
Phone : +91-11-43526658
Mobile : +91-9873336444
icon
Skype : Oddway2010
WeChat : Oddway2010
icon
WhatsApp : +91-9873336444
Viber : +91-9873336444

India | 中文 | Россия

All information provided on this web site (www.OddwayInternational.com) property of "Oddway International" is provided for information purposes only and does not constitute a legal contract between this site and any person or entity unless otherwise specified. Information on this site is subject to change without prior notice. Although every reasonable effort is made to present current and accurate information, the site makes no guarantees of any kind. The web site may contain information (including but not limited to medical content, images, videos, blogs and news articles) that is created and maintained by a variety of sources both internal and external to it. These internal urls / sites are unmoderated forums containing the personal opinions and other expressions of the persons who post the content / entries. The site does not control, monitor or guarantee the information contained in these internal urls / sites or information contained in links to other external web sites, and does not endorse any views expressed or products or services offered therein. In no event shall the site be responsible or liable, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with the use of or reliance on any such content, goods, or services available on or through any such site or resource. This site does not provide any medical advise and the content of this site should not be a substitute for professional medical advise, diagnosis or any treatment.

Top